with chronic Lyme disease symptoms that resemble those of other chronic fatigue or pain syndromes. Another would be to determine whether there is a genetic vulnerability to central sensitivity syndromes, which might offer a productive approach to better identify those at risk. Good biomarkers for post-Lyme disease are not yet available. However, conceptualizing the disease as having roots in central nervous system dysfunction could help chart the way.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement